+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


VistaGen Therapeutics Inc (VTGN) - Financial and Strategic SWOT Analysis Review

  • ID: 4278398
  • SWOT Analysis
  • March 2018
  • 25 pages
  • GlobalData

VistaGen Therapeutics Inc (VistaGen) is a clinical-stage biopharmaceutical company that offers drug development, rescue and discovery and regenerative medicine. The company provides human heart cells and liver cells by using its proprietary human pluripotent stems cell technology. Its pipeline product portfolio includes AV-101, which is a prodrug candidate used in the treatment of central nervous system disorders such as major depressive disorder, refractory epilepsy, chronic neuropathic pain and Parkinson’s disease. VistaGen's CardioSafe 3D and LiverSafe 3D are preclinical in vitro bioassays that are used to assess new drug candidates potentiality for cardiac toxicity. VistaGen is headquartered in South San Francisco, California, the US.

VistaGen Therapeutics Inc Key Recent Developments

Feb 12, 2018: VistaGen Therapeutics Reports Third Quarter Fiscal 2018 Financial Results
Dec 08, 2017: VistaGen Therapeutics Expands Stem Cell Patent Portfolio with New U.S. Patent on Methods for Producing Blood Cells, Platelets and Bone Marrow Stem Cells with Potential to Treat Autoimmune Disorders and Cancer
Nov 09, 2017: VistaGen Therapeutics Reports Second Fiscal Quarter 2018 Financial Results and Provides Business Update
Aug 21, 2017: VistaGen Therapeutics Expands VistaStem's Scientific Advisory Board with Appointment of Medicinal Chemistry Expert, David Rotella, PhD
Aug 14, 2017: VistaGen Therapeutics Reports First Fiscal Quarter 2018 Financial Results and Provides Business Update

This comprehensive SWOT profile of VistaGen Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of VistaGen Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
Section 1 - About the Company
  • VistaGen Therapeutics Inc - Key Information
  • VistaGen Therapeutics Inc - Overview
  • VistaGen Therapeutics Inc - Key Employees
  • VistaGen Therapeutics Inc - Key Employee Biographies
  • VistaGen Therapeutics Inc - Key Operational Heads
  • VistaGen Therapeutics Inc - Major Products and Services
  • VistaGen Therapeutics Inc - History
  • VistaGen Therapeutics Inc - Company Statement
  • VistaGen Therapeutics Inc - Locations And Subsidiaries
  • VistaGen Therapeutics Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • VistaGen Therapeutics Inc - Business Description
  • VistaGen Therapeutics Inc - Corporate Strategy
  • VistaGen Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • VistaGen Therapeutics Inc - Strengths
  • VistaGen Therapeutics Inc - Weaknesses
  • VistaGen Therapeutics Inc - Opportunities
  • VistaGen Therapeutics Inc - Threats
  • VistaGen Therapeutics Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • VistaGen Therapeutics Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • VistaGen Therapeutics Inc, Key Information
  • VistaGen Therapeutics Inc, Key Ratios
  • VistaGen Therapeutics Inc, Share Data
  • VistaGen Therapeutics Inc, Major Products and Services
  • VistaGen Therapeutics Inc, History
  • VistaGen Therapeutics Inc, Key Employees
  • VistaGen Therapeutics Inc, Key Employee Biographies
  • VistaGen Therapeutics Inc, Key Operational Heads
  • VistaGen Therapeutics Inc, Other Locations
  • VistaGen Therapeutics Inc, Subsidiaries
  • VistaGen Therapeutics Inc, Key Manufacturing facilities
  • VistaGen Therapeutics Inc, Key Competitors
  • VistaGen Therapeutics Inc, SWOT Analysis
  • VistaGen Therapeutics Inc, Ratios based on current share price
  • VistaGen Therapeutics Inc, Annual Ratios
  • VistaGen Therapeutics Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • VistaGen Therapeutics Inc, Performance Chart
  • VistaGen Therapeutics Inc, Ratio Charts
Note: Product cover images may vary from those shown